World Trade Center Health Program Scientific/Technical Advisory Committee (WTCHP STAC), 2995 [2018-00968]

Download as PDF Federal Register / Vol. 83, No. 14 / Monday, January 22, 2018 / Notices Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–00967 Filed 1–19–18; 8:45 am] BILLING CODE 4160–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES SUPPLEMENTARY INFORMATION: Centers for Disease Control and Prevention [Docket Number: CDC–2018–0002; NIOSH 248–G] World Trade Center Health Program Scientific/Technical Advisory Committee (WTCHP STAC) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC National Institute for Occupational Safety and Health (NIOSH), announces the following meeting for the World Trade Center Health Program Scientific/ Technical Advisory Committee (WTCHP STAC). This meeting is open to the public, limited only by the number of telephone lines. The room will accommodate approximately 100 persons. The public is also welcome to listen to the meeting by dial-in number 1 (888) 982–4611, the passcode 3778171, and will accommodate up to 50 callers. To view the web conference, enter the following web address in your web browser: https:// odniosh.adobeconnect.com/ wtchpstac18-1/. DATES: The meeting will be held on March 1, 2018, 9:00 a.m. to 4:00 p.m., EST. Public comment time will be from 9:15 a.m. to 9:30 a.m., EST. Please note that the public comment period ends at the time indicated above or following the last call for comments, whichever is earlier. Members of the public who want to comment must sign up by providing their name to Mia Wallace, Committee Management Specialist, by phone: (404) 498–2553, email: MWallace@cdc.gov, or the addresses provided below by February 16, 2018. Each commenter will be provided up to five minutes for comment. A limited number of time slots are available and will be assigned on a first come—first served basis. Written comments will also be accepted ethrower on DSK3G9T082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 19:00 Jan 19, 2018 Jkt 244001 from those unable to attend the public session. ADDRESSES: Jacob J. Javits Federal Building, 26 Federal Plaza, New York, New York 10278. FOR FURTHER INFORMATION CONTACT: Paul J. Middendorf, Ph.D., Designated Federal Officer, NIOSH, CDC, 2400 Century Parkway NE, Mail Stop E–20, Atlanta, Georgia 30345, telephone 1 (888) 982–4748; email: wtc-stac@ cdc.gov. Background: The Advisory Committee was established by Title I of the James Zadroga 9/11 Health and Compensation Act of 2010, Public Law 111–347 (January 2, 2011), amended by Public Law 114–113 (Dec. 18, 2015), adding Title XXXIII to the Public Health Service Act (codified at 42 U.S.C. 300mm to 300mm–61). Purpose: The purpose of the Advisory Committee is to review scientific and medical evidence and to make recommendations to the World Trade Center (WTC) Program Administrator regarding additional WTC Health Program eligibility criteria, potential additions to the list of covered WTCrelated health conditions, and research regarding certain health conditions related to the September 11, 2001 terrorist attacks. Title XXXIII of the PHS Act established the WTC Health Program within the Department of Health and Human Services (HHS). The WTC Health Program provides medical monitoring and treatment benefits to eligible firefighters and related personnel, law enforcement officers, and rescue, recovery, and cleanup workers who responded to the September 11, 2001, terrorist attacks in New York City, at the Pentagon, and in Shanksville, Pennsylvania (responders), and to eligible persons who were present in the dust or dust cloud on September 11, 2001 or who worked, resided, or attended school, childcare, or adult daycare in the New York City disaster area (survivors). Certain specific activities of the WTC Program Administrator are reserved to the Secretary, HHS, to delegate at her discretion; other WTC Program Administrator duties not explicitly reserved to the Secretary, HHS, are assigned to the Director, NIOSH. The administration of the Advisory Committee is left to the Director of NIOSH in his role as WTC Program Administrator. CDC and NIOSH provide funding, staffing, and administrative support services for the Advisory Committee. The charter was reissued on PO 00000 Frm 00038 Fmt 4703 Sfmt 9990 2995 May 12, 2017, and will expire on May 12, 2019. Policy on Redaction of Committee Meeting Transcripts (Public Comment): Transcripts will be prepared and posted to https://www.regulations.gov within 60 days after the meeting. If a person making a comment gives his or her name, no attempt will be made to redact that name. NIOSH will take reasonable steps to ensure that individuals making public comments are aware of the fact that their comments (including their name, if provided) will appear in a transcript of the meeting posted on a public website. Such reasonable steps include a statement read at the start of the meeting stating that transcripts will be posted and names of speakers will not be redacted. If individuals in making a statement reveal personal information (e.g., medical information) about themselves, that information will not usually be redacted. The CDC Freedom of Information Act coordinator will, however, review such revelations in accordance with the Freedom of Information Act and, if deemed appropriate, will redact such information. Disclosures of information concerning third party medical information will be redacted. Matters To Be Considered: The agenda will include discussions on recommendations regarding the identification of individuals to conduct independent peer reviews of the evidence that would be the basis for issuing final rules to add a health condition to the List of WTC-Related Health Conditions, and World Trade Center Health-Related Research. Agenda items are subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–00968 Filed 1–19–18; 8:45 am] BILLING CODE 4163–19–P E:\FR\FM\22JAN1.SGM 22JAN1

Agencies

[Federal Register Volume 83, Number 14 (Monday, January 22, 2018)]
[Notices]
[Page 2995]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00968]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket Number: CDC-2018-0002; NIOSH 248-G]


World Trade Center Health Program Scientific/Technical Advisory 
Committee (WTCHP STAC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
National Institute for Occupational Safety and Health (NIOSH), 
announces the following meeting for the World Trade Center Health 
Program Scientific/Technical Advisory Committee (WTCHP STAC). This 
meeting is open to the public, limited only by the number of telephone 
lines. The room will accommodate approximately 100 persons. The public 
is also welcome to listen to the meeting by dial-in number 1 (888) 982-
4611, the passcode 3778171, and will accommodate up to 50 callers. To 
view the web conference, enter the following web address in your web 
browser: https://odniosh.adobeconnect.com/wtchpstac18-1/.

DATES: The meeting will be held on March 1, 2018, 9:00 a.m. to 4:00 
p.m., EST. Public comment time will be from 9:15 a.m. to 9:30 a.m., 
EST.
    Please note that the public comment period ends at the time 
indicated above or following the last call for comments, whichever is 
earlier. Members of the public who want to comment must sign up by 
providing their name to Mia Wallace, Committee Management Specialist, 
by phone: (404) 498-2553, email: [email protected], or the addresses 
provided below by February 16, 2018. Each commenter will be provided up 
to five minutes for comment. A limited number of time slots are 
available and will be assigned on a first come--first served basis. 
Written comments will also be accepted from those unable to attend the 
public session.

ADDRESSES: Jacob J. Javits Federal Building, 26 Federal Plaza, New 
York, New York 10278.

FOR FURTHER INFORMATION CONTACT: Paul J. Middendorf, Ph.D., Designated 
Federal Officer, NIOSH, CDC, 2400 Century Parkway NE, Mail Stop E-20, 
Atlanta, Georgia 30345, telephone 1 (888) 982-4748; email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Background: The Advisory Committee was established by Title I of 
the James Zadroga 9/11 Health and Compensation Act of 2010, Public Law 
111-347 (January 2, 2011), amended by Public Law 114-113 (Dec. 18, 
2015), adding Title XXXIII to the Public Health Service Act (codified 
at 42 U.S.C. 300mm to 300mm-61).
    Purpose: The purpose of the Advisory Committee is to review 
scientific and medical evidence and to make recommendations to the 
World Trade Center (WTC) Program Administrator regarding additional WTC 
Health Program eligibility criteria, potential additions to the list of 
covered WTC-related health conditions, and research regarding certain 
health conditions related to the September 11, 2001 terrorist attacks.
    Title XXXIII of the PHS Act established the WTC Health Program 
within the Department of Health and Human Services (HHS). The WTC 
Health Program provides medical monitoring and treatment benefits to 
eligible firefighters and related personnel, law enforcement officers, 
and rescue, recovery, and cleanup workers who responded to the 
September 11, 2001, terrorist attacks in New York City, at the 
Pentagon, and in Shanksville, Pennsylvania (responders), and to 
eligible persons who were present in the dust or dust cloud on 
September 11, 2001 or who worked, resided, or attended school, 
childcare, or adult daycare in the New York City disaster area 
(survivors). Certain specific activities of the WTC Program 
Administrator are reserved to the Secretary, HHS, to delegate at her 
discretion; other WTC Program Administrator duties not explicitly 
reserved to the Secretary, HHS, are assigned to the Director, NIOSH. 
The administration of the Advisory Committee is left to the Director of 
NIOSH in his role as WTC Program Administrator. CDC and NIOSH provide 
funding, staffing, and administrative support services for the Advisory 
Committee. The charter was reissued on May 12, 2017, and will expire on 
May 12, 2019.
    Policy on Redaction of Committee Meeting Transcripts (Public 
Comment): Transcripts will be prepared and posted to https://www.regulations.gov within 60 days after the meeting. If a person 
making a comment gives his or her name, no attempt will be made to 
redact that name. NIOSH will take reasonable steps to ensure that 
individuals making public comments are aware of the fact that their 
comments (including their name, if provided) will appear in a 
transcript of the meeting posted on a public website. Such reasonable 
steps include a statement read at the start of the meeting stating that 
transcripts will be posted and names of speakers will not be redacted. 
If individuals in making a statement reveal personal information (e.g., 
medical information) about themselves, that information will not 
usually be redacted. The CDC Freedom of Information Act coordinator 
will, however, review such revelations in accordance with the Freedom 
of Information Act and, if deemed appropriate, will redact such 
information. Disclosures of information concerning third party medical 
information will be redacted.
    Matters To Be Considered: The agenda will include discussions on 
recommendations regarding the identification of individuals to conduct 
independent peer reviews of the evidence that would be the basis for 
issuing final rules to add a health condition to the List of WTC-
Related Health Conditions, and World Trade Center Health-Related 
Research. Agenda items are subject to change as priorities dictate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2018-00968 Filed 1-19-18; 8:45 am]
 BILLING CODE 4163-19-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.